Ligachem Biosciences Inc. (141080) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ligachem Biosciences Inc. (141080:KRX), powered by AI.

Current Price
₩198,000
P/E Ratio
874.1
Market Cap
7.2T
Sector
Healthcare
What is the Ligachem Biosciences Inc. stock price forecast?

Ligachem Biosciences Inc. is currently trading at ₩198,000. View real-time AI analysis on Alpha Lenz.

What is Ligachem Biosciences Inc. insider trading activity?

View the latest insider trading data for Ligachem Biosciences Inc. on Alpha Lenz.

What is Ligachem Biosciences Inc.'s P/E ratio?

Ligachem Biosciences Inc.'s P/E ratio is 874.1.

Ligachem Biosciences Inc.

KRX · 141080
₩198,000
Ask about Ligachem Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Ligachem Biosciences Inc. trades at a P/E of 874.1 (premium valuation) with modest ROE of 2.0%. 3Y revenue CAGR of 57.6% highlights clear growth momentum.

Ask for details

Company Overview

Ligachem Biosciences Inc. is a prominent player in the biopharmaceutical industry, primarily engaged in the discovery and development of innovative therapeutic solutions. The company focuses on leveraging cutting-edge research and advanced biotechnology to address unmet medical needs globally. Through its strategic R&D initiatives, Ligachem Biosciences Inc. develops a diverse pipeline of drug candidates aimed at treating a wide range of diseases, including rare genetic disorders, cancer, and infectious diseases. The company operates in collaboration with academic institutions, healthcare providers, and pharmaceutical companies to accelerate the process of bringing new treatments to market. By prioritizing the integration of scientific expertise and technology, Ligachem Biosciences Inc. plays a critical role in advancing healthcare and improving patient outcomes worldwide. Its commitment to innovation and collaboration distinguishes it within the competitive landscape of biotechnology, contributing significantly to the industry's growth and evolution.

CEO김용주
SectorHealthcare
IndustryBiotechnology
Employees170

Company Statistics

FY 2024

Profile

₩7,248,846,924,000Market Cap
₩125,898,140,990Revenue
36.61MShares Out
170Employees

Margins

87.33%Gross
7.65%EBITDA
-16.61%Operating
7.25%Pre-Tax
6.20%Net

Valuation

874.09P/E
11.07P/B
54.15EV/Sales
694.16EV/EBITDA
93.68P/FCF

Growth (CAGR)

57.61%Rev 3Yr
16.97%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
-8.96%Net Inc 5Yr

Returns

1.68%ROA
2.04%ROE
2.08%ROIC

Financial Health

₩128,912,155,240Cash & Cash Equivalents
₩-6,527,352,460Net Debt
19.87%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ligachem Biosciences Inc. (ticker: 141080) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 170 employees. Market cap is $7.2T.

The current price is ₩198,000 with a P/E ratio of 874.09x and P/B of 11.07x.

ROE is 2.04% and operating margin is -16.61%. Annual revenue is $125.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ligachem Biosciences Inc. (Healthcare) Stock Forecast & Analysis ₩198,000 | Alpha Lenz